Actively Recruiting
Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Led by University of Pennsylvania · Updated on 2026-02-13
20
Participants Needed
2
Research Sites
25 weeks
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurately to user generated input. The investigative team, in collaboration with the Penn Mixed Methods Research Lab (MMRL) and Penn's Way 2 Health Team, will use intervention mapping guided by the Consolidated Framework for Implementation Science. The investigators will conduct a needs assessment, assemble an advisory board, engage in pretesting to ensure safety and refine content, and pilot test the resultant adapted Penny COPILOT in a sample of 20 perinatal women with OUD to evaluate acceptability, feasibility, and patient satisfaction. The goal is to develop and refine an acceptable, feasible, and satisfactory supportive texting chatbot to promote patient engagement in perinatal and OUD care and decrease perceived loneliness.
CONDITIONS
Official Title
Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biological females who are currently pregnant or within 6 weeks postpartum.
- Able to read, write, and speak English at a 6th grade level.
- Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder.
- Receiving prenatal care and OUD care at a Penn affiliated hospital.
You will not qualify if you...
- Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital of the University of Pennsylvania (HUP)
Philadelphia, Pennsylvania, United States, 19072
Actively Recruiting
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104-3309
Not Yet Recruiting
Research Team
S
Sara L Kornfield, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here